CFO sees 2013 net revenue up 0.75 percent - 2 percent * CFO sees 2013 retail sales up 1.25-2.5 percent, same-store sales up 0.25-1.5 percent
CFO sees 2013 pbm net revenue growth 1.5-2.75 percent
CFO sees 2013 operating profit margin up 30-40 basis points in retail and pbm
CFO sees greater profit benefit from generics in 2013 than seen in 2012
CFO says resolved walgreen/express scripts impasse should add at least 12.5
cents to 2012 EPS *
CFO says captured more than fair share of Walgreen prescriptions
CFO says currently expects to retain at least 60 percent of prescriptions
Wow...wow and wow!!
This was all within my expectations. I though it was going to pop. I like what I see and feel okay to hold and buy on dips. My feeling the company will go on an acquisition spree to grow larger and more international.